| Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients EP Krenning, DJ Kwekkeboom, WH Bakker, WAP Breeman, PPM Kooij, ... European journal of nuclear medicine 20, 716-731, 1993 | 2021 | 1993 |
| An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist I Aksentijevich, SL Masters, PJ Ferguson, P Dancey, J Frenkel, ... New England Journal of Medicine 360 (23), 2426-2437, 2009 | 1090 | 2009 |
| The EUROclass trial: defining subgroups in common variable immunodeficiency C Wehr, T Kivioja, C Schmitt, B Ferry, T Witte, E Eren, M Vlkova, ... Blood, The Journal of the American Society of Hematology 111 (1), 77-85, 2008 | 1006 | 2008 |
| Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide EP Krenning, WH Bakker, PPM Kooij, WAP Breeman, HY Oei, M De Jong, ... Journal of Nuclear Medicine 33 (5), 652-658, 1992 | 623 | 1992 |
| Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib VK Rao, S Webster, VASH Dalm, A Šedivá, PM van Hagen, S Holland, ... Blood, The Journal of the American Society of Hematology 130 (21), 2307-2316, 2017 | 293 | 2017 |
| The effect of etanercept on Graves' ophthalmopathy: a pilot study D Paridaens, WA Van den Bosch, TL Van der Loos, EP Krenning, ... Eye 19 (12), 1286-1289, 2005 | 266 | 2005 |
| Reviewing primary Sjögren's syndrome: beyond the dryness-from pathophysiology to diagnosis and treatment T Both, VASH Dalm, PM van Hagen, PLA van Daele International journal of medical sciences 14 (3), 191, 2017 | 250 | 2017 |
| Anti-TNF-α therapy for sight threatening uveitis EW Lindstedt, GS Baarsma, R Kuijpers, PM Van Hagen British Journal of Ophthalmology 89 (5), 533-536, 2005 | 247 | 2005 |
| Evaluation of a radiolabelled cyclic DTPA‐RGD analogue for tumour imaging and radionuclide therapy PM Van Hagen, WAP Breeman, HF Bernard, M Schaar, CM Mooij, ... International journal of cancer 90 (4), 186-198, 2000 | 233 | 2000 |
| In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats WH Bakker, EP Krenning, JC Reubi, WAP Breeman, B Setyono-Han, ... Life sciences 49 (22), 1593-1601, 1991 | 227 | 1991 |
| Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg-and Th2-dominated phenotype K van der Weerd, WA Dik, B Schrijver, DH Schweitzer, AW Langerak, ... Diabetes 61 (2), 401-408, 2012 | 219 | 2012 |
| Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells VASH Dalm, PM Van Hagen, PM Van Koetsveld, S Achilefu, ... American Journal of Physiology-Endocrinology and Metabolism 285 (2), E344-E353, 2003 | 219 | 2003 |
| Somatostatin and the immune and haematopoetic system; a review. PM Van Hagen, EP Krenning, DJ Kwekkeboom, JC Reubi, ... European Journal of Clinical Investigation 24 (2), 91-99, 1994 | 209 | 1994 |
| IgG4-related disease: a systematic review of this unrecognized disease in pediatrics F Karim, J Loeffen, W Bramer, L Westenberg, R Verdijk, M van Hagen, ... Pediatric Rheumatology 14, 1-9, 2016 | 196 | 2016 |
| Somatostatin and somatostatin receptors in the immune system: a review. AMC ten Bokum, LJ Hofland, PM van Hagen European cytokine network 11 (2), 161-76, 2000 | 188 | 2000 |
| Defective maturation and function of antigen-presenting cells in type 1 diabetes A Jansen, M Van Hagen, HA Drexhage The Lancet 345 (8948), 491-492, 1995 | 178 | 1995 |
| Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes JC Van Meurs, E ter Averst, LJ Hofland, PM Van Hagen, CM Mooy, ... British Journal of Ophthalmology 88 (1), 110-113, 2004 | 165 | 2004 |
| Successful treatment of CRPS 1 with anti-TNF FJPM Huygen, S Niehof, FJ Zijlstra, PM van Hagen, PLA van Daele Journal of pain and symptom management 27 (2), 101-103, 2004 | 146 | 2004 |
| B-cell replication history and somatic hypermutation status identify distinct pathophysiologic backgrounds in common variable immunodeficiency GJ Driessen, MC Van Zelm, PM Van Hagen, NG Hartwig, M Trip, A Warris, ... Blood, The Journal of the American Society of Hematology 118 (26), 6814-6823, 2011 | 145 | 2011 |
| in vitro and in vivo detection of somatostatin receptors in human malignant lymphomas JC Reubi, B Waser, M Van Hagen, SWJ Lamberts, EP Krenning, ... International journal of cancer 50 (6), 895-900, 1992 | 143 | 1992 |
